138 related articles for article (PubMed ID: 17543084)
21. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
[TBL] [Abstract][Full Text] [Related]
22. Expression of Snail1 in the vimentin-expressing squamous cell carcinoma mimicking atypical fibroxanthoma: possible involvement of an epithelial-mesenchymal transition.
Nakamura M; Sugita K; Tokura Y
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1365-6. PubMed ID: 20384675
[No Abstract] [Full Text] [Related]
23. Trichilemmal cyst with carcinoma in situ within an atypical fibroxanthoma.
Arsenovic N; Sen S; Naik V; Reed M; Moreira R
Am J Dermatopathol; 2009 Aug; 31(6):587-90. PubMed ID: 19590414
[TBL] [Abstract][Full Text] [Related]
24. Atypical fibroxanthoma arising in an area of syringocystadenoma papilliferum associated with nevus sebaceus: positivity of the atypical fibroxanthoma component for CD31.
Tronnier M; Vogelbruch M
J Cutan Pathol; 2007 Dec; 34 Suppl 1():58-63. PubMed ID: 17997741
[TBL] [Abstract][Full Text] [Related]
25. Re: CD117 immunoreactivity in atypical fibroxanthoma.
Barr KL; Russo JJ; Vincek V
Am J Dermatopathol; 2009 Feb; 31(1):96-8. PubMed ID: 19155737
[No Abstract] [Full Text] [Related]
26. Atypical fibroxanthoma: a clinicopathological study of 89 cases.
Mirza B; Weedon D
Australas J Dermatol; 2005 Nov; 46(4):235-8. PubMed ID: 16197421
[TBL] [Abstract][Full Text] [Related]
27. The histopathologic spectrum of regression in atypical fibroxanthoma.
Stefanato CM; Robson A; Calonje JE
J Cutan Pathol; 2010 Mar; 37(3):310-5. PubMed ID: 19765173
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory leiomyosarcoma of the retroperitoneum.
Morović A; Delcore R; Damjanov I
Pathol Res Pract; 2003; 199(1):41-3; discussion 45-6. PubMed ID: 12650517
[TBL] [Abstract][Full Text] [Related]
29. An unusual presentation of atypical fibroxanthoma.
Vandergriff TW; Reed JA; Orengo IF
Dermatol Online J; 2008 Jan; 14(1):6. PubMed ID: 18319023
[TBL] [Abstract][Full Text] [Related]
30. Atypical fibroxanthoma/malignant fibrous histiocytoma.
Marcet S
Dermatol Ther; 2008; 21(6):424-7. PubMed ID: 19076618
[TBL] [Abstract][Full Text] [Related]
31. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
[TBL] [Abstract][Full Text] [Related]
32. CD117 is not a useful marker for diagnosing atypical fibroxanthoma.
Barr KL; Russo JJ; Vincek V
Am J Dermatopathol; 2010 Jul; 32(5):528. PubMed ID: 20526172
[No Abstract] [Full Text] [Related]
33. Atypical fibroxanthoma: a selective review.
Gru AA; Santa Cruz DJ
Semin Diagn Pathol; 2013 Feb; 30(1):4-12. PubMed ID: 23327726
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
35. Aspects of the differential diagnosis of clear-cell lesions of the skin in connection with the rare case of a clear-cell atypical fibroxanthoma.
Kemmerling R; Dietze O; Müller S; Neureiter D
Pathol Res Pract; 2009; 205(5):365-70. PubMed ID: 19155147
[TBL] [Abstract][Full Text] [Related]
36. AFX: what we now know.
McCalmont TH
J Cutan Pathol; 2011 Nov; 38(11):853-6. PubMed ID: 21955311
[No Abstract] [Full Text] [Related]
37. Suppression of Gadd45 alleviates the G2/M blockage and the enhanced phosphorylation of p53 and p38 in zinc supplemented normal human bronchial epithelial cells.
Shih RS; Wong SH; Schoene NW; Lei KY
Exp Biol Med (Maywood); 2008 Mar; 233(3):317-27. PubMed ID: 18296737
[TBL] [Abstract][Full Text] [Related]
38. Atypical fibroxanthoma in a child without xeroderma pigmentosum.
Berk DR; Lind AC; Tapia B; Kane AA; Bayliss SJ
Pediatr Dermatol; 2007; 24(4):450-2. PubMed ID: 17845192
[No Abstract] [Full Text] [Related]
39. [Clinical aspects and pathology of malignant fibrous histiocytoma].
Zöller J; Born IA; Manke HG; Drommer RB
Fortschr Kiefer Gesichtschir; 1988; 33():25-9. PubMed ID: 2842244
[No Abstract] [Full Text] [Related]
40. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
